Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NT$ 21.8
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Inalways Corporation engages in the electronic and power supply components manufacturing, and medical biotechnology businesses in Taiwan. The company offers health related foods, medical equipment, indicated medication, and prescribed drugs. The company was formerly known as Liwei Industrial Co., Ltd and changed its name to Inalways Corporation in July 2017. Inalways Corporation was founded in...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued
Data is available to registered users only
Buy
Sell